Results 151 to 160 of about 198,971 (363)

Surgery of the Aortic Valve [PDF]

Postgraduate Medical Journal, 1961
openaire   +2 more sources

Robotic mitral valve surgery

Frontiers in Cardiovascular Medicine
Totally endoscopic robotic mitral valve repair is the least invasive surgical therapy for mitral valve disease. Robotic mitral valve surgery demonstrates faster recovery with shorter hospital stays, less morbidity, and equivalent mortality and mid-term durability compared to sternotomy.
John Massey, Kenneth Palmer, Omar Al-Rawi, Owen Chambers, Tim Ridgway, Selvaraj Shanmuganathan, Gopal Soppa, Paul Modi   +7 more
openaire   +3 more sources

Clinical Evaluation of on-Table Extubation in Patients Aged Over 60 Years Undergoing Minimally Invasive Mitral or Aortic Valve Replacement Surgery [PDF]

, 2022
Yunfen Ge, Yue Chen, Zhibin Hu, Hui Mao, Qiong Xu, Qing Wu   +5 more
openalex   +1 more source

Cerebrovascular Events in Aortic Stenosis: From Native Valve Disease to TAVR‐Specific Risk and Prevention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger, Jamschid Sedighi, Martin Juenemann, Omar Alhaj‐Omar, Kerstin Piayda, Mani Arsalan, Samuel Sossalla, Won‐Keun Kim   +7 more
wiley   +1 more source

Pregnancy Outcomes in Women With Mechanical Valve Prostheses Using Vitamin K Antagonist Therapy: The Experience of the Salam Centre for Cardiac Surgery in Sudan [PDF]

, 2022
Nicoletta Erba, Sofia Gatti, Suha Abdelwahab Abdalla Hassan, Martin Langer, Liliane Chatenoud, Gina Portella, Raffaela Baiocchi   +6 more
openalex   +1 more source

Commentary: Find the plane. Carefully dissect. Snip. Repeat. And beware the elephant!Central Message

JTCVS Techniques, 2020
Gaetano Paone, MD, MHSA
doaj   +1 more source

Clinical and Echocardiographic Outcomes After Implantation of the ALLEGRA Transcatheter Valve Using the Fully Repositionable IMPERIA Delivery System: One‐Year Results of the EMPIRE I Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz, Claire B. Ren, Christof Burgdorf, Christian Frerker, Ignacio Cruz‐González, Joan Antoni Gómez, José Maria Hernândez, Pilar Jimenez, Ernest Spitzer, Pim Tonino, Pieter Vriesendorp, Nicolas van Mieghem, Samuel Copt, Anders Jönsson, Keith G. Oldroyd, Nicolas Doll   +15 more
wiley   +1 more source

Commentary: Transapical transapical mitral valve replacement: Here to stay or a gateway procedure?Central Message

JTCVS Techniques, 2020
J. James Edelman, MBBS(Hons), PhD, James Kauten, MD, Vinod H. Thourani, MD   +2 more
doaj   +1 more source

Commando procedure in a radiated chestCentral Message

JTCVS Techniques, 2022
Jennifer L. Perri, MD, MBA, Douglas R. Johnston, MD   +1 more
doaj   +1 more source

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source